Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Dow
Johnson and Johnson
AstraZeneca
Medtronic

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Technetium tc-99m oxidronate kit - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for technetium tc-99m oxidronate kit and what is the scope of patent protection?

Technetium tc-99m oxidronate kit is the generic ingredient in one branded drug marketed by Curium and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m oxidronate kit. One supplier is listed for this compound.

Recent Litigation for technetium tc-99m oxidronate kit

Identify potential future generic entrants

District Court Litigation
Case NameDate
Tripharma LLC v. First Fruits Business Ministry LLC2012-03-14

See all technetium tc-99m oxidronate kit litigation

US Patents and Regulatory Information for technetium tc-99m oxidronate kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for technetium tc-99m oxidronate kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Curium TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Merck
McKesson
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.